Beta Bionics Inc (NASDAQ:BBNX) has seen 1.23 million shares traded in the last trading session. The company, currently valued at $747.53M, closed the last trade at $17.24 per share which meant it gained $1.88 on the day or 12.24% during that session. The BBNX stock price is -42.11% off its 52-week high price of $24.50 and 48.43% above the 52-week low of $8.89.

Beta Bionics Inc (NASDAQ:BBNX) trade information

Sporting 12.24% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BBNX stock price touched $17.24 or saw a rise of 0.86%. Year-to-date, Beta Bionics Inc shares have moved -27.04%, while the 5-day performance has seen it change 11.15%. Over the past 30 days, the shares of Beta Bionics Inc (NASDAQ:BBNX) have changed 56.02%.

Earnings growth for 2025 is a modest 74.20% while over the next 5 years, the company’s earnings are expected to increase by 38.83%.

BBNX Dividends

Beta Bionics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are JANUS INVESTMENT FUND-Janus Henderson Venture Fund and AB CAP FUND, INC.-AB Small Cap Growth Portfolio . As of Mar 31, 2025 , the former fund manager holds about 1.47% shares in the company for having 635.91 shares of worth $10.96 million while later fund manager owns 561.12 shares of worth $9.67 million as of Mar 31, 2025 , which makes it owner of about 1.29% of company’s outstanding stock.